ESPR logo

Esperion Therapeutics (ESPR) Current Assets

Annual Current Assets

$201.06 M
-$45.62 M-18.49%

31 December 2023

ESPR Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$307.56 M
-$37.55 M-10.88%

30 September 2024

ESPR Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ESPR Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-18.5%+40.9%
3 y3 years-41.9%+80.2%
5 y5 years+41.0%+21.3%

ESPR Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-41.9%at low-15.9%+80.2%
5 y5 years-41.9%+41.0%-15.9%+80.2%
alltimeall time-41.9%>+9999.0%-15.9%+4208.5%

Esperion Therapeutics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$307.56 M(-10.9%)
June 2024
-
$345.11 M(-5.6%)
Mar 2024
-
$365.61 M(+81.8%)
Dec 2023
$4.73 M(+276.7%)
$201.06 M(-7.9%)
Sept 2023
-
$218.23 M(-6.0%)
June 2023
-
$232.13 M(-7.4%)
Mar 2023
-
$250.60 M(+1.6%)
Dec 2022
$1.26 M(-97.6%)
$246.68 M(-5.8%)
Sept 2022
-
$261.79 M(+3.7%)
June 2022
-
$252.48 M(-13.2%)
Mar 2022
-
$290.82 M(-11.6%)
Dec 2021
$52.62 M(+614.7%)
$328.97 M(+92.8%)
Sept 2021
-
$170.67 M(-38.0%)
June 2021
-
$275.17 M(+1.0%)
Mar 2021
-
$272.57 M(-21.2%)
Dec 2020
$7.36 M(+169.4%)
$345.90 M(+42.5%)
Sept 2020
-
$242.80 M(-24.4%)
June 2020
-
$321.37 M(+86.2%)
Mar 2020
-
$172.63 M(-18.5%)
Dec 2019
$2.73 M(+233.7%)
$211.71 M(-16.5%)
Sept 2019
-
$253.46 M(-17.5%)
June 2019
-
$307.12 M(+30.6%)
Mar 2019
-
$235.22 M(+64.9%)
Dec 2018
$819.00 K
$142.63 M(-15.2%)
Sept 2018
-
$168.21 M(-10.9%)
June 2018
-
$188.88 M(-6.2%)
DateAnnualQuarterly
Mar 2018
-
$201.41 M(-1.2%)
Dec 2017
$73.91 M(+133.6%)
$203.92 M(-1.4%)
Sept 2017
-
$206.82 M(+21.0%)
June 2017
-
$170.95 M(-9.1%)
Mar 2017
-
$188.01 M(-12.0%)
Dec 2016
$31.64 M(-61.0%)
$213.58 M(+0.1%)
Sept 2016
-
$213.47 M(+2.1%)
June 2016
-
$209.09 M(+6.1%)
Mar 2016
-
$197.05 M(-8.1%)
Dec 2015
$81.18 M(+121.9%)
$214.39 M(-2.0%)
Sept 2015
-
$218.84 M(-3.0%)
June 2015
-
$225.71 M(-19.3%)
Mar 2015
-
$279.83 M(+162.3%)
Dec 2014
$36.58 M(+107.0%)
$106.70 M(+95.5%)
Sept 2014
-
$54.58 M(-11.0%)
June 2014
-
$61.32 M(+5.2%)
Mar 2014
-
$58.28 M(-3.9%)
Dec 2013
$17.67 M(>+9900.0%)
$60.62 M(-16.9%)
Sept 2013
-
$72.96 M(+276.3%)
June 2013
-
$19.39 M(-12.4%)
Mar 2013
-
$22.12 M(+209.9%)
Dec 2012
$174.00 K(-44.9%)
$7.14 M
Dec 2011
$315.70 K(-94.9%)
-
Dec 2002
$6.14 M(-12.9%)
-
Dec 2001
$7.05 M(+7.9%)
-
Dec 2000
$6.54 M(+234.2%)
-
Dec 1999
$1.96 M
-

FAQ

  • What is Esperion Therapeutics annual total current assets?
  • What is the all time high annual current assets for Esperion Therapeutics?
  • What is Esperion Therapeutics annual current assets year-on-year change?
  • What is Esperion Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Esperion Therapeutics?
  • What is Esperion Therapeutics quarterly current assets year-on-year change?

What is Esperion Therapeutics annual total current assets?

The current annual current assets of ESPR is $201.06 M

What is the all time high annual current assets for Esperion Therapeutics?

Esperion Therapeutics all-time high annual total current assets is $345.90 M

What is Esperion Therapeutics annual current assets year-on-year change?

Over the past year, ESPR annual total current assets has changed by -$45.62 M (-18.49%)

What is Esperion Therapeutics quarterly total current assets?

The current quarterly current assets of ESPR is $307.56 M

What is the all time high quarterly current assets for Esperion Therapeutics?

Esperion Therapeutics all-time high quarterly total current assets is $365.61 M

What is Esperion Therapeutics quarterly current assets year-on-year change?

Over the past year, ESPR quarterly total current assets has changed by +$89.33 M (+40.93%)